Cargando…

Neural Drive Impairment in Chronic Kidney Disease Patients Is Associated with Neuromuscular Fatigability and Fatigue

INTRODUCTION: Chronic kidney disease (CKD) patients have a high degree of fatigue relating to neuromuscular symptoms. There is a lack of evidence regarding the etiology of neuromuscular fatigability in elderly CKD patients. METHODS: Inclusion criteria are as follows: age ≥60 yr, glomerular filtratio...

Descripción completa

Detalles Bibliográficos
Autores principales: CHATRENET, ANTOINE, PICCOLI, GIORGINA, ANTHIERENS, AGATHE, TORREGGIANI, MASSIMO, AUDEBRAND, JEAN MICHEL, MOREL, BAPTISTE, BEAUNE, BRUNO, DURAND, SYLVAIN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997639/
https://www.ncbi.nlm.nih.gov/pubmed/36508212
http://dx.doi.org/10.1249/MSS.0000000000003090
_version_ 1784903298368667648
author CHATRENET, ANTOINE
PICCOLI, GIORGINA
ANTHIERENS, AGATHE
TORREGGIANI, MASSIMO
AUDEBRAND, JEAN MICHEL
MOREL, BAPTISTE
BEAUNE, BRUNO
DURAND, SYLVAIN
author_facet CHATRENET, ANTOINE
PICCOLI, GIORGINA
ANTHIERENS, AGATHE
TORREGGIANI, MASSIMO
AUDEBRAND, JEAN MICHEL
MOREL, BAPTISTE
BEAUNE, BRUNO
DURAND, SYLVAIN
author_sort CHATRENET, ANTOINE
collection PubMed
description INTRODUCTION: Chronic kidney disease (CKD) patients have a high degree of fatigue relating to neuromuscular symptoms. There is a lack of evidence regarding the etiology of neuromuscular fatigability in elderly CKD patients. METHODS: Inclusion criteria are as follows: age ≥60 yr, glomerular filtration rate (GFR) <45 mL·min(−1) per 1.73 m(2) in CKD patients, and GFR >60 mL·min(−1)·1.73 m(−2) in controls. The fatigability protocol consisted in a submaximal handgrip task at 40% peak force. Fatigue was assessed using the Multidimensional Fatigue Inventory–20 items (MFI-20) and the Functional Assessment of Chronic Illness Therapy–Fatigue questionnaires. Peak rate of force development (RFD(peak), normalized: NRFD(peak)) and rate of EMG rise (RER) were measured during explosive contractions; peak force and mean surface EMG were measured during maximum voluntary contractions. Multilevel models tested neuromuscular parameters adjusted for clinical and Multidimensional Fatigue Inventory–20 items subscales. Neuromuscular fatigability contribution to fatigue description was tested using model comparison. RESULTS: The study included 102 participants; 45 CKD patients and 57 controls. CKD mainly affected the mental and the reduced motivation subscales of fatigue. CKD was associated with greater neuromuscular fatigability assessed using NRFD(peak) (group–time interaction, −16.7 % MVF·s(−1), P = 0.024), which increased with fatigue severity (P = 0.018) and with a higher rate of decrement in RER compared with controls (RER at 50 ms: β = −121.2 μV·s(−1), P = 0.016, and β = −48.5 μV·s(−1), P = 0.196, respectively). Furthermore, these patients show an association between the reduced motivation subscale and the RER (e.g., 30 ms: β = −59.8% EMG(peak)·s(−1), P < 0.001). Only peak force fatigability contributed to fatigue variance, whereas RFD(peak) did not. CONCLUSIONS: In CKD patients, the neuromuscular fatigability assessed using RFD(peak) is related to an impairment in motor-unit recruitment or discharge rates, whereas only peak force fatigability was related to fatigue. This suggests that targeting exercise interventions might lessen fatigue and improve quality of life in CKD patients.
format Online
Article
Text
id pubmed-9997639
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-99976392023-03-09 Neural Drive Impairment in Chronic Kidney Disease Patients Is Associated with Neuromuscular Fatigability and Fatigue CHATRENET, ANTOINE PICCOLI, GIORGINA ANTHIERENS, AGATHE TORREGGIANI, MASSIMO AUDEBRAND, JEAN MICHEL MOREL, BAPTISTE BEAUNE, BRUNO DURAND, SYLVAIN Med Sci Sports Exerc Applied Sciences INTRODUCTION: Chronic kidney disease (CKD) patients have a high degree of fatigue relating to neuromuscular symptoms. There is a lack of evidence regarding the etiology of neuromuscular fatigability in elderly CKD patients. METHODS: Inclusion criteria are as follows: age ≥60 yr, glomerular filtration rate (GFR) <45 mL·min(−1) per 1.73 m(2) in CKD patients, and GFR >60 mL·min(−1)·1.73 m(−2) in controls. The fatigability protocol consisted in a submaximal handgrip task at 40% peak force. Fatigue was assessed using the Multidimensional Fatigue Inventory–20 items (MFI-20) and the Functional Assessment of Chronic Illness Therapy–Fatigue questionnaires. Peak rate of force development (RFD(peak), normalized: NRFD(peak)) and rate of EMG rise (RER) were measured during explosive contractions; peak force and mean surface EMG were measured during maximum voluntary contractions. Multilevel models tested neuromuscular parameters adjusted for clinical and Multidimensional Fatigue Inventory–20 items subscales. Neuromuscular fatigability contribution to fatigue description was tested using model comparison. RESULTS: The study included 102 participants; 45 CKD patients and 57 controls. CKD mainly affected the mental and the reduced motivation subscales of fatigue. CKD was associated with greater neuromuscular fatigability assessed using NRFD(peak) (group–time interaction, −16.7 % MVF·s(−1), P = 0.024), which increased with fatigue severity (P = 0.018) and with a higher rate of decrement in RER compared with controls (RER at 50 ms: β = −121.2 μV·s(−1), P = 0.016, and β = −48.5 μV·s(−1), P = 0.196, respectively). Furthermore, these patients show an association between the reduced motivation subscale and the RER (e.g., 30 ms: β = −59.8% EMG(peak)·s(−1), P < 0.001). Only peak force fatigability contributed to fatigue variance, whereas RFD(peak) did not. CONCLUSIONS: In CKD patients, the neuromuscular fatigability assessed using RFD(peak) is related to an impairment in motor-unit recruitment or discharge rates, whereas only peak force fatigability was related to fatigue. This suggests that targeting exercise interventions might lessen fatigue and improve quality of life in CKD patients. Lippincott Williams & Wilkins 2023-04 2022-12-13 /pmc/articles/PMC9997639/ /pubmed/36508212 http://dx.doi.org/10.1249/MSS.0000000000003090 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American College of Sports Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Applied Sciences
CHATRENET, ANTOINE
PICCOLI, GIORGINA
ANTHIERENS, AGATHE
TORREGGIANI, MASSIMO
AUDEBRAND, JEAN MICHEL
MOREL, BAPTISTE
BEAUNE, BRUNO
DURAND, SYLVAIN
Neural Drive Impairment in Chronic Kidney Disease Patients Is Associated with Neuromuscular Fatigability and Fatigue
title Neural Drive Impairment in Chronic Kidney Disease Patients Is Associated with Neuromuscular Fatigability and Fatigue
title_full Neural Drive Impairment in Chronic Kidney Disease Patients Is Associated with Neuromuscular Fatigability and Fatigue
title_fullStr Neural Drive Impairment in Chronic Kidney Disease Patients Is Associated with Neuromuscular Fatigability and Fatigue
title_full_unstemmed Neural Drive Impairment in Chronic Kidney Disease Patients Is Associated with Neuromuscular Fatigability and Fatigue
title_short Neural Drive Impairment in Chronic Kidney Disease Patients Is Associated with Neuromuscular Fatigability and Fatigue
title_sort neural drive impairment in chronic kidney disease patients is associated with neuromuscular fatigability and fatigue
topic Applied Sciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997639/
https://www.ncbi.nlm.nih.gov/pubmed/36508212
http://dx.doi.org/10.1249/MSS.0000000000003090
work_keys_str_mv AT chatrenetantoine neuraldriveimpairmentinchronickidneydiseasepatientsisassociatedwithneuromuscularfatigabilityandfatigue
AT piccoligiorgina neuraldriveimpairmentinchronickidneydiseasepatientsisassociatedwithneuromuscularfatigabilityandfatigue
AT anthierensagathe neuraldriveimpairmentinchronickidneydiseasepatientsisassociatedwithneuromuscularfatigabilityandfatigue
AT torreggianimassimo neuraldriveimpairmentinchronickidneydiseasepatientsisassociatedwithneuromuscularfatigabilityandfatigue
AT audebrandjeanmichel neuraldriveimpairmentinchronickidneydiseasepatientsisassociatedwithneuromuscularfatigabilityandfatigue
AT morelbaptiste neuraldriveimpairmentinchronickidneydiseasepatientsisassociatedwithneuromuscularfatigabilityandfatigue
AT beaunebruno neuraldriveimpairmentinchronickidneydiseasepatientsisassociatedwithneuromuscularfatigabilityandfatigue
AT durandsylvain neuraldriveimpairmentinchronickidneydiseasepatientsisassociatedwithneuromuscularfatigabilityandfatigue